Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Jul 8;11:551. doi: 10.3389/fneur.2020.00551

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2020 Li, Dong, Liu, Zou, Hao, Gao, Pan and Liang.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Effects of nigericin, NEK7 small interfering RNA and MCC950 treatment on neurological outcome. (A) SAH grading score at 24 and 72 h after SAH (B,C) Modified Garcia test and Beam balance test at 24 h after SAH. n = 6 for each group. (D) Representative immunohistochemistry images of TUNEL (red) and NeuN (green) at 24 h after SAH. Scale Bar=20 μm. (E) Apoptotic ratios of each group, n = 6. *: vs. sham P < 0.05, &: vs. SAH+Vehicle P < 0.05, and #: vs. SAH+nigericin+Scr siRNA P < 0.05.